These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25426555)

  • 21. Glycine Decarboxylase Expression Increased in p53-Mutated B Cell Lymphoma Mice.
    Li X; Cui C; Guo Y; Yang G
    Oncol Res Treat; 2015; 38(11):586-9. PubMed ID: 26599272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.
    Zhang Z; Li J; Lantry LE; Wang Y; Wiseman RW; Lubet RA; You M
    Cancer Res; 2002 Jun; 62(11):3024-9. PubMed ID: 12036908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolution of thymic lymphomas in p53 knockout mice.
    Dudgeon C; Chan C; Kang W; Sun Y; Emerson R; Robins H; Levine AJ
    Genes Dev; 2014 Dec; 28(23):2613-20. PubMed ID: 25452272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Unique Spectrum of Spontaneous Tumors in
    Marney CB; Anderson ES; Baum R; Schmitt AM
    Cells; 2022 Jun; 11(11):. PubMed ID: 35681513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development.
    Dubé N; Bourdeau A; Heinonen KM; Cheng A; Loy AL; Tremblay ML
    Cancer Res; 2005 Nov; 65(21):10088-95. PubMed ID: 16267035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic interactions between Pten and p53 in radiation-induced lymphoma development.
    Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A
    Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A mammary-specific model demonstrates the role of the p53 tumor suppressor gene in tumor development.
    Jerry DJ; Kittrell FS; Kuperwasser C; Laucirica R; Dickinson ES; Bonilla PJ; Butel JS; Medina D
    Oncogene; 2000 Feb; 19(8):1052-8. PubMed ID: 10713689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
    Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
    Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas.
    Snijders AM; Liu Y; Su L; Huang Y; Mao JH
    Oncotarget; 2015 Dec; 6(42):44794-805. PubMed ID: 26575021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 protects against skin cancer induction by UV-B radiation.
    Jiang W; Ananthaswamy HN; Muller HK; Kripke ML
    Oncogene; 1999 Jul; 18(29):4247-53. PubMed ID: 10435637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Bcl11b genotypes and gamma-radiation on the development of mouse thymic lymphomas.
    Yoshikai Y; Sato T; Morita S; Kohara Y; Takagi R; Mishima Y; Kominami R
    Biochem Biophys Res Commun; 2008 Aug; 373(2):282-5. PubMed ID: 18558082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.
    Eischen CM; Rehg JE; Korsmeyer SJ; Cleveland JL
    Cancer Res; 2002 Apr; 62(7):2184-91. PubMed ID: 11929842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
    Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
    Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A spatially and temporally restricted mouse model of soft tissue sarcoma.
    Kirsch DG; Dinulescu DM; Miller JB; Grimm J; Santiago PM; Young NP; Nielsen GP; Quade BJ; Chaber CJ; Schultz CP; Takeuchi O; Bronson RT; Crowley D; Korsmeyer SJ; Yoon SS; Hornicek FJ; Weissleder R; Jacks T
    Nat Med; 2007 Aug; 13(8):992-7. PubMed ID: 17676052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
    Loehberg CR; Thompson T; Kastan MB; Maclean KH; Edwards DG; Kittrell FS; Medina D; Conneely OM; O'Malley BW
    Cancer Res; 2007 Dec; 67(24):12026-33. PubMed ID: 18089834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rats deficient for p53 are susceptible to spontaneous and carcinogen-induced tumorigenesis.
    Yan HX; Wu HP; Ashton C; Tong C; Ying QL
    Carcinogenesis; 2012 Oct; 33(10):2001-5. PubMed ID: 22791818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis.
    Hussain SP; Trivers GE; Hofseth LJ; He P; Shaikh I; Mechanic LE; Doja S; Jiang W; Subleski J; Shorts L; Haines D; Laubach VE; Wiltrout RH; Djurickovic D; Harris CC
    Cancer Res; 2004 Oct; 64(19):6849-53. PubMed ID: 15466171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homozygous and heterozygous p53 knockout rats develop metastasizing sarcomas with high frequency.
    van Boxtel R; Kuiper RV; Toonen PW; van Heesch S; Hermsen R; de Bruin A; Cuppen E
    Am J Pathol; 2011 Oct; 179(4):1616-22. PubMed ID: 21854749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Susceptibility of wild and knockout p53 FVB/N line mice to benz(a)pyrene-induced subcutaneous sarcoma].
    Anikin IV; Kozlov AP; Popov AV; Zabezhinskiĭ MA; Tyndyk ML; Anisimov VN
    Vopr Onkol; 2002; 48(6):700-2. PubMed ID: 12530267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of major genome instability in tumors of p53 null rats.
    Hermsen R; Toonen P; Kuijk E; Youssef SA; Kuiper R; van Heesch S; de Bruin A; Cuppen E; Simonis M
    PLoS One; 2015; 10(3):e0122066. PubMed ID: 25811670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.